C07AA03 - Pindolol |
Probably not porphyrinogenic |
PNP |
Rationale
Beta-blocker. Clinical experience and two references point to non-porphyrinogenicity.
Chemical description
Beta-receptor blocking agent used in hypertension, angina pectoris, tachyarrythmia. Eliminated unchanged (30-40%) and as metabolites.
Personal communication
Thunell, patient reports (n=3): tolerated.
Andersson, patient reports (n=3): tolerated.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | EPI List
European Porphyria Initiative No longer maintained
|
|
| 2. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames
Visken 
Visken 
Pindolol · Visken 
Pindol · Pindolol · Visken · Viskén 
Visken 
Pindol · Pindolol · Visken · Vypen 
Pindolol · Visken 
Visken 
Betadren · Pindolol · Pindolol component of viskazide · Visken 
Pindolol